About this podcast:
This presentation from the 2025 IO360º Summit focuses on the immunological effects of radiopharmaceuticals, presented by Chaitanya Divgi, Sr Strategic Expert, Therapeutic Innovation, at Novartis. 

Specifically, this podcast dives deeper into: 

• An introduction to radioligand therapy
• A focus on PSMA-targeted radionuclide therapy
• Prelimary work on the relationship between systemic radiation therapy and immune effects at the tumor level 

For more information, visit IO360summit.com